María E. Reig1 , 2

Hepatology · 2010–2021

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom María E. Reig1 , 2 trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2
  2. J. Llovet
  3. Riccardo Lencioni
  4. P. Kamath

Who trusts María E. Reig1 , 2 overall

  1. Amit G. Singal
  2. J. Pawlotsky
  3. Jorge Marrero

Papers from María E. Reig1 , 2's perspective

Ordered by how strongly the researchers María E. Reig1 , 2 trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  2. Molecular Targeted Therapies in Hepatocellular Carcinoma (Hepatology)
  3. A System of Classifying Microvascular Invasion to Predict Outcome after Resection in Patients with Hepatocellular Carcinoma (Gastroenterology)
  4. Diagnosis and treatment of hepatocellular carcinoma. (Gastroenterology)
  5. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling (Molecular Cancer Therapeutics)
  6. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. (Gastroenterology)
  7. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. (Radiology)
  8. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial , (Journal of Hepatology)
  9. Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma (Cancer Research)
  10. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)

Their papers